UK-78282 is a novel, potent and selective Kv1.3 blocker with an IC50 of 200 nM. UK-78282 effectively suppresses human T-lymphocyte activation in vitro. UK-78282 binds to residues at the inner surface of the channel overlapping the site of action of verapamil.
UK-78282 is a novel, potent and selective Kv1.3 blocker with an IC50 of 200 nM. UK-78282 effectively suppresses human T-lymphocyte activation in vitro. UK-78282 binds to residues at the inner surface of the channel overlapping the site of action of verapamil.
UK-78282 is a novel, potent and selective Kv1.3 blocker with an IC50 of 200 nM. UK-78282 effectively suppresses human T-lymphocyte activation in vitro. UK-78282 binds to residues at the inner surface of the channel overlapping the site of action of verapamil.
UK-78282 is a novel, potent and selective Kv1.3 blocker with an IC50 of 200 nM. UK-78282 effectively suppresses human T-lymphocyte activation in vitro. UK-78282 binds to residues at the inner surface of the channel overlapping the site of action of verapamil.
UK-78282 is a novel, potent and selective Kv1.3 blocker with an IC50 of 200 nM. UK-78282 effectively suppresses human T-lymphocyte activation in vitro. UK-78282 binds to residues at the inner surface of the channel overlapping the site of action of verapamil.
UKI-1 is a novel synthetic inhibitor of the urokinase-type plasminogen activator, which inhibits the invasive capacity of carcinoma cells with a Ki of 0.41 μM.
UKI-1 is a novel synthetic inhibitor of the urokinase-type plasminogen activator, which inhibits the invasive capacity of carcinoma cells with a Ki of 0.41 μM.
Uliledlimab is a potent against CD73 humanized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
Uliledlimab is a potent against CD73 humanized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
Ulinastatin Ulinastatin is an inhibitor of serine protease and urinary trypsin with anti-inflammatory activity and is used in studies related to pancreatitis, sepsis and septic shock.
Ulinastatin Ulinastatin is an inhibitor of serine protease and urinary trypsin with anti-inflammatory activity and is used in studies related to pancreatitis, sepsis and septic shock.
Ulinastatin Ulinastatin is an inhibitor of serine protease and urinary trypsin with anti-inflammatory activity and is used in studies related to pancreatitis, sepsis and septic shock.